Pseudo-Ginsenoside GQ

伪人参皂苷GQ

Report date: 2022/08/04 11:01:20
NME

Base Information

Drug NamePseudo-Ginsenoside GQ
Drug Alias NamePGQ注射液人参二醇组皂苷经定向结构修饰得到的全新化合物
ClassificationNatural product/ExtractSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockersBeta-1 adrenergic receptor antagonists
TargetsVoltage-gated calcium channelBeta-1 adrenergic receptor
Therapy Area/IndicationsAngina PectorisMyocardial Ischemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesJilin Huakang Pharmaceutical Co LtdInstitute Of Regenerative Medicine Science, Jilin University
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJilin Huakang Pharmaceutical Co LtdInstitute Of Regenerative Medicine Science, Jilin University
Inactive CompaniesN/A
Active IndicationsAngina Pectoris
Inactive IndicationsMyocardial Ischemia

Other Information

ATC CodeN/A
Related LinksN/A